A Phase II Trial to Assess Hemodynamic Effects of Istaroxime in Pts With Worsening HF and Reduced LV Systolic Function (HORIZON-HF)

This study has been completed.
Information provided by sigma-tau i.f.r. S.p.A.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Heart Failure
2		More general conditions related to this trial
			Cardiovascular Diseases
			Heart Diseases
3		Interventions listed in this trial
			Istaroxime
			Placebo
4		Sponsors listed in this trial
			sigma-tau i.f.r. S.p.A.
			MDS Pharma Services